News

Duska is in the process of modifying the proposed design of the Phase III clinical trial in accordance with the FDA’s comments and plans to submit a revised

Both NeuroMove and TruWave devices have previously received the FDA’s clearance for marketing in the US. NeuroMove is marketed for stroke and spinal cord injury rehabilitation and TruWave

Results also showed that for patients in the trial taking rosuvastatin: the combined risk of heart attack, stroke or cardiovascular (CV) death was reduced by nearly half (47%,

The CNAP Monitor 500 measures non-invasive and continuous blood pressure in real-time and can predict responsiveness to fluid administration. In the perioperative setting, detecting blood pressure drops and

Under the terms of the agreement the kits will be manufactured by Nanogen and branded as Menarini products. The first products are expected to be introduced to the

The DiaGenic BCtect breast cancer test will be marketed in India through Religare SRL (formerly known as SRL Ranbaxy), a laboratory chain in South East Asia. India was

Centre Hospitalier Universitaire d’Angers (CHU d’Angers) has received a grant from the Programme Hospitalier de Recherche Clinique – National, a program under the French Ministry of Health, to

In each Phase II study, VIA-2291 inhibited production of leukotrienes, proposed mediators of vascular inflammation. VIA-2291 was generally well-tolerated, the company said. According to the company, the first

With the addition of Mr Corbett and Mr Pelak, the Vertos board expands to six members. Mr Corbett has more than 28 years of leadership experience in the